Literature DB >> 1263731

Complications of treatment with clofazimine (Lamprene: B663).

W H Jopling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1263731     DOI： 10.5935/0305-7518.19760001

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  3 in total

1.  Intra-neural ceroid-like pigment following the treatment of lepromatous leprosy with clofazimine (B663; Lamprene).

Authors:  A C McDougall; R L Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

Review 2.  Clinical pharmacokinetics of clofazimine. A review.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

3.  Quantitative Analysis of the Phase Transition Mechanism Underpinning the Systemic Self-Assembly of a Mechanopharmaceutical Device.

Authors:  Steven Dunne; Andrew R Willmer; Rosemary Swanson; Deepak Almeida; Nicole C Ammerman; Kathleen A Stringer; Edmund V Capparelli; Gus R Rosania
Journal:  Pharmaceutics       Date:  2021-12-22       Impact factor: 6.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.